1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Portage Biotech: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma TT-10, TT-4 - Renal Cell Cancer, Castrate Resistant Prostate Cancer | Phase 1 / Phase 2 | Recruiting | Portage Biotech | 35 | 2023-06-23 | 2026-09-15 |
Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Mesothelioma, Malignant (1)
United States (1)